Risk of contrast-induced nephropathy in hospitalized patients with cirrhosis

World Journal of Gastroenterology

Volumn 15, Issue 12, 2009, Pages 1459-1464

  Lodhia, Nilesh ^a   Kader, Michael ^a   Mayes, Thalia ^a   Mantry, Parvez ^a   Maliakkal, Benedict ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Ascites; Cirrhosis; Contrast induced nephropathy; Renal failure

Indexed keywords

CONTRAST MEDIUM; IOHEXOL; DIURETIC AGENT;

ADULT; AGED; ARTICLE; ASCITES; CHRONIC KIDNEY FAILURE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST INDUCED NEPHROPATHY; CREATININE CLEARANCE; FEMALE; HIGH RISK PATIENT; HOSPITAL PATIENT; HUMAN; INCIDENCE; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; CHEMICALLY INDUCED DISORDER; KIDNEY DISEASE; MIDDLE AGED; RACE;

AGED; ASCITES; CONTINENTAL POPULATION GROUPS; CONTRAST MEDIA; DIURETICS; FEMALE; HUMANS; INCIDENCE; INPATIENTS; KIDNEY DISEASES; LIVER CIRRHOSIS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 65549108787     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.15.1459     Document Type: Article

References (50)

1. Ginès A, Escorsell A, Ginès P, Saló J, Jiménez W, Inglada Navasa M, Claria J, Rimola A, Arroyo V. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology 1993; 105: 229-236
2. Wu CC, Yeung LK, Tsai WS, Tseng CF, Chu P, Huang TY, Lin YF, Lu KC. Incidence and factors predictive of acute renal failure in patients with advanced liver cirrhosis. Clin Nephrol 2006; 65: 28-33
3. du Cheyron D, Bouchet B, Parienti JJ, Ramakers M, Charbonneau P. The attributable mortality of acute renal failure in critically ill patients with liver cirrhosis. Intensive Care Med 2005; 31: 1693-1699
4. Alessandria C, Ozdogan O, Guevara M, Restuccia T, Jiménez W, Arroyo V, Rodés J, Ginès P. MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation. Hepatology 2005; 41: 1282-1289
5. Epstien M. Deranged renal function in liver disease. Contrib Nephrol 1977; 7: 250-271
6. Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality. A cohort analysis. JAMA 1996; 275: 1489-1494
7. Dangas G, Iakovou I, Nikolsky E, Aymong ED, Mintz GS, Kipshidze NN, Lansky AJ, Moussa I, Stone GW, Moses JW, Leon MB, Mehran R. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol 2005; 95: 13-19
8. Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, Mintz GS, Lansky AJ, Moses JW, Stone GW, Leon MB, Dangas G. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 2004; 44: 1393-1399
9. From AM, Bar tholmai BJ, Williams AW, Cha SS, McDonald FS. Mortality associated with nephropathy after radiographic contrast exposure. Mayo Clin Proc 2008; 83: 1095-1100
10. Mathew R, Haque K, Woothipoom W. Acute renal failure induced by contrast medium: steps towards prevention. BMJ 2006; 333: 539-540
11. Manske CL, Sprafka JM, Strony JT, Wang Y. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med 1990; 89: 615-620
12. Nikolsky E, Mehran R, Lasic Z, Mintz GS, Lansky AJ, Na Y, Pocock S, Negoita M, Moussa I, Stone GW, Moses JW, Leon MB, Dangas G. Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions. Kidney Int 2005; 67: 706-713
13. Abraham PA, Kjellstrand CM. Contrast media nephropathy. In: Massry SG, Glassock RJ. Textbook of nephrology. 2nd ed. Baltimore: Williams & Wilkins, 1989: 851-859
14. Moreau R, Lebrec D. Acute renal failure in patients with cirrhosis: perspectives in the age of MELD. Hepatology 2003; 37: 233-243
15. Barrett BJ, Parfrey PS. Prevention of nephrotoxicity induced by radiocontrast agents. N Engl J Med 1994; 331: 1449-1450
16. Barrett BJ. Contrast nephrotoxicity. J Am Soc Nephrol 1994; 5: 125-137
17. Barrett BJ, Parfrey PS. Clinical practice. Preventing nephropathy induced by contrast medium. N Engl J Med 2006; 354: 379-386
18. Guevara M, Fernández-Esparrach G, Alessandria C, Torre A, Terra C, Montañà X, Piera C, Alvarez ML, Jiménez W, Ginès P, Arroyo V. Effects of contrast media on renal function in patients with cirrhosis: a prospective study. Hepatology 2004; 40: 646-651
19. Najjar M, Hamad A, Salameh M, Agarwal A, Feinfeld DA. The risk of radiocontrast nephropathy in patients with cirrhosis. Ren Fail 2002; 24: 11-18
20. Heyman SN, Reichman J, Brezis M. Pathophysiology of radiocontrast nephropathy: a role for medullary hypoxia. Invest Radiol 1999; 34: 685-691
21. Brezis M, Rosen S. Hypoxia of the renal medulla - its implications for disease. N Engl J Med 1995; 332: 647-655
22. Brezis M, Agmon Y, Epstein FH. Determinants of intrarenal oxygenation. I. Effects of diuretics. Am J Physiol 1994; 267: F1059-F1062
23. Humes HD, Hunt DA, White MD. Direct toxic effect of the radiocontrast agent diatrizoate on renal proximal tubule cells. Am J Physiol 1987; 252: F246-F255
24. Deray G, Martinez F, Cacoub P, Baumelou B, Baumelou A, Jacobs C. A role for adenosine calcium and ischemia in radiocontrast-induced intrarenal vasoconstriction. Am J Nephrol 1990; 10: 316-322
25. Heyman SN, Clark BA, Kaiser N, Spokes K, Rosen S, Brezis M, Epstein FH. Radiocontrast agents induce endothelin release in vivo and in vitro. J Am Soc Nephrol 1992; 3: 58-65
26. Baud L, Ardaillou R. Reactive oxygen species: production and role in the kidney. Am J Physiol 1986; 251: F765-F776
27. Bakris GL, Lass N, Gaber AO, Jones JD, Burnett JC Jr. Radiocontrast medium-induced declines in renal function: a role for oxygen free radicals. Am J Physiol 1990; 258: F115-F120
28. Baliga R, Ueda N, Walker PD, Shah SV. Oxidant mechanisms in toxic acute renal failure. Am J Kidney Dis 1997; 29: 465-477
29. Mudge GH. Uricosuric action of cholecystographic agents. A possible factor in nephrotoxicity. N Engl J Med 1971; 284: 929-933
30. Postlethwaite AE, Kelley WN. Uricosuric effect of radiocontrast agents. A study in man of four commonly used preparations. Ann Intern Med 1971; 74: 845-852
31. Schwartz RH, Berdon WE, Wagner J, Becker J, Baker DH. Tamm-Horsfall urinary mucoprotein precipitation by urographic contrast agents: in vitro studies. Am J Roentgenol Radium Ther Nucl Med 1970; 108: 698-701
32. Solomon R, Werner C, Mann D, D'Elia J, Silva P. Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 1994; 331: 1416-1420
33. Mueller C, Buerkle G, Buettner HJ, Petersen J, Perruchoud AP, Eriksson U, Marsch S, Roskamm H. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 2002; 162: 329-336
34. Merten GJ, Burgess WP, Gray LV, Holleman JH, Roush TS, Kowalchuk GJ, Bersin RM, Van Moore A, Simonton CA 3rd, Rittase RA, Norton HJ, Kennedy TP. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 2004; 291: 2328-2334
35. Trivedi HS, Moore H, Nasr S, Aggarwal K, Agrawal A, Goel P, Hewett J. A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron Clin Pract 2003; 93: C29-C34
36. Mueller-Lenke N, Buerkle G, Klima T, Breidthardt T, Buettner HJ, Mueller C. Incidence of contrast-induced nephropathy with volume supplementation - insights from a large cohort. Med Princ Pract 2008; 17: 409-414
37. Parfrey PS, Griffiths SM, Barrett BJ, Paul MD, Genge M, Withers J, Farid N, McManamon PJ. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med 1989; 320: 143-149
38. Brar SS, Shen AY, Jorgensen MB, Kotlewski A, Aharonian VJ, Desai N, Ree M, Shah AI, Burchette RJ. Sodium bicarbonate vs sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography: a randomized trial. JAMA 2008; 300: 1038-1046
39. Ustundag Y, Samsar U, Acikgoz S, Cabuk M, Kiran S, Kulah E, Aydemir S. Analysis of glomerular filtration rate, serum cystatin C levels, and renal resistive index values in cirrhosis patients. Clin Chem Lab Med 2007; 45: 890-894
40. Cholongitas E, Shusang V, Marelli L, Nair D, Thomas M, Patch D, Burns A, Sweny P, Burroughs AK. Review article: renal function assessment in cirrhosis - difficulties and alternative measurements. Aliment Pharmacol Ther 2007; 26: 969-978
41. Pöge U, Gerhardt T, Stoffel-Wagner B, Klehr HU, Sauerbruch T, Woitas RP. Calculation of glomerular filtration rate based on cystatin C in cirrhotic patients. Nephrol Dial Transplant 2006; 21: 660-664
42. Cárdenas A, Ginès P, Uriz J, Bessa X, Salmerón JM, Mas A, Ortega R, Calahorra B, De Las Heras D, Bosch J, Arroyo V, Rodes J. Renal failure after upper gastrointestinal bleeding in cirrhosis: incidence, clinical course, predictive factors, and short-term prognosis. Hepatology 2001; 34: 671-676
43. Terra C, Guevara M, Torre A, Gilabert R, Fernández J, Martín-Llahí M, Baccaro ME, Navasa M, Bru C, Arroyo V, Rodes J, Gines P. Renal failure in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis: value of MELD score. Gastroenterology 2005; 129: 1944-1953
44. Fraley DS, Burr R, Bernardini J, Angus D, Kramer DJ, Johnson JP. Impact of acute renal failure on mortality in end-stage liver disease with or without transplantation. Kidney Int 1998; 54: 518-524
45. Chen YC, Tsai MH, Hsu CW, Ho YP, Lien JM, Chang MY, Fang JT, Huang CC, Chen PC. Role of serum creatinine and prognostic scoring systems in assessing hospital mortality in critically ill cirrhotic patients with upper gastrointestinal bleeding. J Nephrol 2003; 16: 558-565
46. Bagshaw SM, Gibney RT. Conventional markers of kidney function. Crit Care Med 2008; 36: S152-S158
47. Cramer BC, Parfrey PS, Hutchinson TA, Baran D, Melanson DM, Ethier RE, Seely JF. Renal function following infusion of radiologic contrast material. A prospective controlled study. Arch Intern Med 1985; 145: 87-89
48. Heller CA, Knapp J, Halliday J, O'Connell D, Heller RF. Failure to demonstrate contrast nephrotoxicity. Med J Aust 1991; 155: 329-332
49. Rao QA, Newhouse JH. Risk of nephropathy after intravenous administration of contrast material: a critical literature analysis. Radiology 2006; 239: 392-397
50. Newhouse JH, Kho D, Rao QA, Starren J. Frequency of serum creatinine changes in the absence of iodinated contrast material: implications for studies of contrast nephrotoxicity. AJR Am J Roentgenol 2008; 191: 376-382